Literature DB >> 22913577

Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.

Christina Meyer1, Dirk Schepmann, Shuichi Yanagisawa, Junichiro Yamaguchi, Valentina Dal Col, Erik Laurini, Kenichiro Itami, Sabrina Pricl, Bernhard Wünsch.   

Abstract

To explore the hydrophobic binding region of the σ(1) receptor protein, regioisomeric spirocyclic thiophenes 9-11 were developed as versatile building blocks. Regioselective α- and β-arylation using the catalyst systems PdCl(2)/bipy/Ag(2)CO(3) and PdCl(2)/P[OCH(CF(3))(2)](3)/Ag(2)CO(3) allowed the introduction of various aryl moieties at different positions in the last step of the synthesis. The increasing σ(1) affinity in the order 4 < 5/6 < 7/8 indicates that the positions of the additional aryl moiety and the S atom in the spirocyclic thiophene systems control the σ(1) affinity. The main features of the pharmacophore model developed for this class of σ(1) ligands are a positive ionizable group, a H-bond acceptor group, two hydrophobic moieties, and one hydrophobic aromatic group. Docking of the ligands into a σ(1) 3D homology model via molecular mechanics/Poisson-Boltzmann surface area calculations led to a very good correlation between the experimentally determined and estimated free energy of receptor binding. These calculations support the hypothesis of a reverse binding mode of ligands bearing the aryl moiety at the "top" (compounds 2, 3, 7, and 8) and "left" (compounds 4, 5, and 6) positions, respectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913577     DOI: 10.1021/jm300894h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 Analogues.

Authors:  Hiromi Sekizawa; Kazuma Amaike; Yukihiro Itoh; Takayoshi Suzuki; Kenichiro Itami; Junichiro Yamaguchi
Journal:  ACS Med Chem Lett       Date:  2014-03-03       Impact factor: 4.345

2.  New arylsparteine derivatives as positive inotropic drugs.

Authors:  Vito Boido; Marcella Ercoli; Michele Tonelli; Federica Novelli; Bruno Tasso; Fabio Sparatore; Elena Cichero; Paola Fossa; Paola Dorigo; Guglielmina Froldi
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations.

Authors:  Mateusz Kurciński; Małgorzata Jarończyk; Piotr F J Lipiński; Jan Cz Dobrowolski; Joanna Sadlej
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

4.  Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.

Authors:  Antonino N Fallica; Valeria Pittalà; Maria N Modica; Loredana Salerno; Giuseppe Romeo; Agostino Marrazzo; Mohamed A Helal; Sebastiano Intagliata
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

5.  Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1'-cyclohexanes] with an exocyclic amino moiety in the 3'-position.

Authors:  Elisabeth Kronenberg; Frauke Weber; Dirk Schepmann; Bernhard Wünsch
Journal:  RSC Med Chem       Date:  2020-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.